NCT07014488

A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects

A Single-center, Single-arm, Open-label, Fixed-sequence Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The study was designed to evaluate the pharmacokinetic effects of Rifampicin on HRS-5041 after oral administration of HRS-5041 tablets in healthy subjects.

Conditions

• Prostate Cancer

Interventions

Type	Name	Description
DRUG	HRS-5041 Tablets	HRS-5041 tablets.
DRUG	Rifampicin Capsule	Rifampicin capsule.

Timeline

• Start date: 2025-06-20
• Primary completion: 2025-08-01
• Completion: 2025-08-01
• First posted: 2025-06-11
• Last updated: 2025-09-10

Locations

1 site across 1 country: China